Literature DB >> 14213328

THE SYNDROME OF NARCOLEPSY AND DIABETOGENIC ("FUNCTIONAL") HYPERINSULINISM, WITH SPECIAL REFERENCE TO OBESITY, DIABETES, IDIOPATHIC EDEMA, CEREBRAL DYSRHYTHMIAS AND MULTIPLE SCLEROSIS (200 PATIENTS).

H J ROBERTS.   

Abstract

Entities:  

Keywords:  ALCOHOLISM; ARRHYTHMIA; CEREBROVASCULAR DISORDERS; DIABETES MELLITUS; DRUG THERAPY; EDEMA; ELECTROENCEPHALOGRAPHY; GLUCOSE TOLERANCE TEST; HYPERINSULINISM; HYPOGLYCEMIA; METHYLPHENIDATE; MULTIPLE SCLEROSIS; NARCOLEPSY; OBESITY; PEPTIC ULCER; SLEEP DISORDERS; UNITED STATES; VASCULAR HEADACHE

Mesh：

Substances：

Year:  1964        PMID： 14213328     DOI： 10.1111/j.1532-5415.1964.tb00642.x

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN： 0002-8614            Impact factor:   5.562


× No keyword cloud information.
  5 in total

1.  [Glucose tolerance testing after intravenous betamethasone phosphate, with concomitant uric acid and cholesterol analyses. A reassessment of both glucocorticoid and afternoon testing in "early chemical diabetes"].

Authors:  H J Roberts
Journal:  Acta Diabetol Lat       Date:  1971 May-Jun

2.  [Oral therapy in "early chemical diabetes". I. Serial glucose, cholesterol and uric acid responses to phenformin].

Authors:  H J Roberts
Journal:  Acta Diabetol Lat       Date:  1969 Oct-Dec

3.  [The value of afternoon glucose tolerance testing in the diagnosis, prognosis and rational treatment of "early chemical diabetes". A five-year experience].

Authors:  H J Roberts
Journal:  Acta Diabetol Lat       Date:  1968 Oct-Dec

4.  Glucose tolerance in patients with narcolepsy.

Authors:  Pierre A Beitinger; Stephany Fulda; Mira A Dalal; Renate Wehrle; Marietta Keckeis; Thomas C Wetter; Fang Han; Thomas Pollmächer; Andreas Schuld
Journal:  Sleep       Date:  2012-02-01       Impact factor: 5.849

5.  Glucose and fat metabolism in narcolepsy and the effect of sodium oxybate: a hyperinsulinemic-euglycemic clamp study.

Authors:  Claire E H M Donjacour; N Ahmad Aziz; Sebastiaan Overeem; Andries Kalsbeek; Hanno Pijl; Gert Jan Lammers
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.